TBL1XR1 and breast carcinoma: The clinical significance of the upregulation of TBLR1 in breast cancer was examined by IHC and correlated with the clinical characteristics of 214 paraffin-embedded breast cancer tissue specimens, including 21 (9.8%) cases with stage I, 107 (50.0%) cases with stage II, 66 (30.8%) cases with stage III and 20 (9.3%) cases with stage IV tumors.